Lv11
90 积分 2023-11-02 加入
Effects of NPY-2 Receptor Antagonists, Semaglutide, PYY3-36, and Empagliflozin on Early MASLD in Diet-Induced Obese Rats
4天前
已完结
Characterization of six clinical drugs and dietary intervention in the non-obese CDAA-HFD mouse model of MASH and progressive fibrosis
15天前
已完结
Discovery of Potent, Orally Bioavailable, Tricyclic NLRP3 Inhibitors
4个月前
已完结
NLRP3 inflammasome in hepatic diseases: A pharmacological target
4个月前
已完结
皖公网安备34019202002308
